109 results on '"Eum S"'
Search Results
2. Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients
- Author
-
Hong, M.-S., Kim, Y., Cho, E.-J., Lee, J.-S., Kwak, H.-K., Kim, J.-H., Kim, C.-T., Cho, J.-S., Park, S.-K., Jeon, D., Choi, Y.-I., Lee, H., and Eum, S.-Y.
- Published
- 2017
- Full Text
- View/download PDF
3. Potential based routing as a secondary best-effort routing for Information Centric Networking (ICN)
- Author
-
Eum, S., Nakauchi, K., Murata, M., Shoji, Y., and Nishinaga, N.
- Published
- 2013
- Full Text
- View/download PDF
4. COVID-19
- Author
-
Brasil Varandas Pinto, A.L., Eum, S., Klippe, W. van de, and Rafols Garcia, I.
- Published
- 2022
5. Ethnic and sex differences in the distributions of body mass index and waist circumference among adults: a binationally representative study in South Korea and the United States.
- Author
-
EUM, S., SON, J. W., MIN, C., CHO, W., KIM, S., WOO, H. G., KWON, R., LEE, K. N., HAN, K.-D., YON, D. K., and RHEE, S. Y.
- Abstract
OBJECTIVE: The ethnic and sex differences in the distributions of body mass index (BMI) and waist circumference (WC) among adults are largely unknown. Therefore, we aimed to investigate the percentiles of BMI and WC in groups divided according to age, sex, and ethnicity. PATIENTS AND METHODS: We conducted a population-based binational study of adults aged =20 years based on data from two sources: US National Health and Nutrition Examination Survey (2015 to 2020) and Korea National Health and Nutrition Examination Survey (2016 to 2019). RESULTS: Weight, height, and WC were measured in 13,144 American adults and 30,191 Korean adults. Overall, BMI increased at younger ages and decreased at older ages, which indicates a reversed U-shaped relationship, and differed in terms of age, sex, and ethnicity. Women in the other Hispanic, non-Hispanic white, non-Hispanic black, and "other ethnic groups" showed a common BMI peak at ages 50-54 years. The patterns of WC distribution were similar to those of BMI distribution. CONCLUSIONS: In this binational representative study, we found varied distributions of ethnic and sex differences in BMI and WC. Considering the differences in these distributions may help improve individual and personalized treatment strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
6. 17-year trends of body mass index, overweight, and obesity among adolescents from 2005 to 2021, including the COVID-19 pandemic: a Korean national representative study.
- Author
-
BAN, C. Y., SHIN, H., EUM, S., YON, H., LEE, S. W., CHOI, Y. S., SHIN, Y. H., SHIN, J. U., KOYANAGI, A., JACOB, L., SMITH, L., MIN, C., YENIOVA, A. Ö., KIM, S. Y., LEE, J., YEO, S.-G., KWON, R., KOO, M. J., FOND, G., and BOYER, L.
- Abstract
OBJECTIVE: There is a lack of pediatric studies that have analyzed trends in mean body mass index (BMI) and the prevalence of obesity and overweight over a period that includes the mid-stage of the COVID-19 pandemic. Thus, we aimed to investigate trends in BMI, overweight, and obesity among Korean adolescents from 2005 to 2021, including the COVID-19 pandemic. SUBJECTS AND METHODS: We used data from the Korea Youth Risk Behavior Web-based Survey (KYRBS), which is nationally representative of South Korea. The study included middleand high-school students between the ages of 12 and 18. We examined trends in mean BMI and prevalence of obesity and/or overweight during the COVID-19 pandemic and compared these to those of pre-pandemic trends in each subgroup by gender, grade, and residential region. RESULTS: Data from 1,111,300 adolescents (mean age: 15.04 years) were analyzed. The estimated weighted mean BMI was 20.48 kg/m2 (95% CI, 20.46-20.51) between 2005 and 2007, and this was 21.61 kg/m2 (95% CI, 21.54-21.68) in 2021. The prevalence of overweight and obesity was 13.1% (95% CI, 12.9-13.3%) between 2005 and 2007 and 23.4% (95% CI, 22.8-24.0%) in 2021. The mean BMI and prevalence of obesity and overweight have gradually increased over the past 17 years; however, the extent of change in mean BMI and in the prevalence of obesity and overweight during the pandemic was distinctly less than before. The 17-year trends in the mean BMI, obesity, and overweight exhibited a considerable rise from 2005 to 2021; however, the slope during the COVID-19 pandemic (2020-2021) was significantly less prominent than in the pre-pandemic (2005-2019). CONCLUSIONS: These findings enable us to comprehend long-term trends in the mean BMI of Korean adolescents and further emphasize the need for practical prevention measures against youth obesity and overweight. [ABSTRACT FROM AUTHOR]
- Published
- 2023
7. Information-Centric Networking (ICN) Research Challenges
- Author
-
Eum, S., additional, Pentikousis, K., additional, Psaras, I., additional, Corujo, D., additional, Saucez, D., additional, Schmidt, T., additional, and Waehlisch, M., additional
- Published
- 2016
- Full Text
- View/download PDF
8. Topological Robustness of Biological Systems for Information Networks—Modularity
- Author
-
Eum, S, primary, Arakawa, S, additional, and Murata, Masayuki, additional
- Published
- 2011
- Full Text
- View/download PDF
9. Information-Centric Networking: Baseline Scenarios
- Author
-
Ohlman, B., additional, Corujo, D., additional, Boggia, G., additional, Tyson, G., additional, Davies, E., additional, Molinaro, A., additional, and Eum, S., additional
- Published
- 2015
- Full Text
- View/download PDF
10. Motor and sensory block of both upper and lower extremities following axillary brachial plexus block using a transarterial approach
- Author
-
Shinn, H. K., Kim, T. J., Lee, C. S., Cha, Y. D., Eum, S. H., and Song, J. H.
- Published
- 2007
11. Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice
- Author
-
EUM, S.-Y., CRÉMINON, C., HAILÉ, S., LEFORT, J., and VARGAFTIG, B. B.
- Published
- 1996
12. Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
- Author
-
Via, L. E., Taylor, K., Allen, S. S., Eum, S. Y., Cho, S. N., Gonzales, J., Raleigh, J. A., Klein, E., Manjunatha, U., Park, S. K., Carrillo, J., McMurray, D. N., Flynn, J. L., Ray, S. M., Lee, E. G., Barry, C. E., and Lin, P. L.
- Abstract
Understanding the physical characteristics of the local microenvironment in which Mycobacterium tuberculosis resides is an important goal that may allow the targeting of metabolic processes to shorten drug regimens. Pimonidazole hydrochloride (Hypoxyprobe) is an imaging agent that is bioreductively activated only under hypoxic conditions in mammalian tissue. We employed this probe to evaluate the oxygen tension in tuberculous granulomas in four animal models of disease: mouse, guinea pig, rabbit, and nonhuman primate. Following infusion of pimonidazole into animals with established infections, lung tissues from the guinea pig, rabbit, and nonhuman primate showed discrete areas of pimonidazole adduct formation surrounding necrotic and caseous regions of pulmonary granulomas by immunohistochemical staining. This labeling could be substantially reduced by housing the animal under an atmosphere of 95% O2. Direct measurement of tissue oxygen partial pressure by surgical insertion of a fiber optic oxygen probe into granulomas in the lungs of living infected rabbits demonstrated that even small (3-mm) pulmonary lesions were severely hypoxic (1.6 ± 0.7 mm Hg). Finally, metronidazole, which has potent bactericidal activity in vitro only under low-oxygen culture conditions, was highly effective at reducing total-lung bacterial burdens in infected rabbits. Thus, three independent lines of evidence support the hypothesis that hypoxic microenvironments are an important feature of some lesions in these animal models of tuberculosis.
- Published
- 2008
- Full Text
- View/download PDF
13. Self-organizing power law topology for the name resolution system of ICN
- Author
-
Eum, S., primary, Arakawa, S., additional, and Murata, M., additional
- Published
- 2014
- Full Text
- View/download PDF
14. Corticobasal syndrome associated with antiphospholipid syndrome without cerebral infarction
- Author
-
Lee, D.-W., primary, Eum, S.-W., additional, Moon, C. O., additional, Ma, H.-I., additional, and Kim, Y. J., additional
- Published
- 2014
- Full Text
- View/download PDF
15. Proinflammatory Adhesion Molecules Facilitate Polychlorinated Biphenyl-Mediated Enhancement of Brain Metastasis Formation
- Author
-
Sipos, E., primary, Chen, L., additional, Andras, I. E., additional, Wrobel, J., additional, Zhang, B., additional, Pu, H., additional, Park, M., additional, Eum, S. Y., additional, and Toborek, M., additional
- Published
- 2012
- Full Text
- View/download PDF
16. HIV-1 Tat Triggers Nuclear Localization of ZO-1 via Rho Signaling and cAMP Response Element-Binding Protein Activation
- Author
-
Zhong, Y., primary, Zhang, B., additional, Eum, S. Y., additional, and Toborek, M., additional
- Published
- 2012
- Full Text
- View/download PDF
17. Development of Lightweight Composite Pallets for Assembly Line of LCDs and PDPs
- Author
-
Kim, Y. H., primary, Eum, S. H., additional, Bae, C. W., additional, Han, J. W., additional, Kim, K. J., additional, Jo, Y. D., additional, and Bae, S. Y., additional
- Published
- 2010
- Full Text
- View/download PDF
18. Process/health monitoring for wind turbine blade by using FBG sensors with multiplexing techniques
- Author
-
Eum, S. H., primary, Kageyama, K., additional, Murayama, H., additional, Uzawa, K., additional, Ohsawa, I., additional, Kanai, M., additional, and Igawa, H., additional
- Published
- 2008
- Full Text
- View/download PDF
19. Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital
- Author
-
Jeon, C. Y., primary, Hwang, S. H., additional, Min, J. H., additional, Prevots, D. R., additional, Goldfeder, L. C., additional, Lee, H., additional, Eum, S. Y., additional, Jeon, D. S., additional, Kang, H. S., additional, Kim, J. H., additional, Kim, B. J., additional, Kim, D. Y., additional, Holland, S. M., additional, Park, S. K., additional, Cho, S. N., additional, Barry, C. E., additional, and Via, L. E., additional
- Published
- 2008
- Full Text
- View/download PDF
20. Structural health monitoring using fiber optic distributed sensors for vacuum-assisted resin transfer molding
- Author
-
Eum, S H, primary, Kageyama, K, additional, Murayama, H, additional, Uzawa, K, additional, Ohsawa, I, additional, Kanai, M, additional, Kobayashi, S, additional, Igawa, H, additional, and Shirai, T, additional
- Published
- 2007
- Full Text
- View/download PDF
21. Self-organizing power law topology for the name resolution system of ICN.
- Author
-
EUM, S., ARAKAWA, S., and MURATA, M.
- Subjects
TOPOLOGY ,SELF-organizing systems ,SIMULATION methods & models - Abstract
A power law topology has interesting topological properties such as low diameter and robustness and so it has been adopted in various network applications. In this paper, we propose algorithms to construct and manage the power law topology in a self-organizing manner, and introduce a use-case of the power law topology as a name resolution system for information-centric networking. Owing to the self-organizing approach, one critical problem in the power law topology, 'fragile for an intentional attack', can be solved in a native manner. We also demonstrate that the global properties of the power law topology such as degree distribution, network distance and clustering coefficient can be manipulated by these proposed algorithms. Moreover, we develop an analytical model and carry out various simulation studies to understand the properties of the constructed power law topologies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
22. A Failure Analysis of the Tomogravity and EM Methods
- Author
-
Eum, S., primary, Murphy, J., additional, and Harris, R., additional
- Published
- 2005
- Full Text
- View/download PDF
23. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells
- Author
-
LEE, Y, primary, EUM, S, additional, NATH, A, additional, and TOBOREK, M, additional
- Published
- 2004
- Full Text
- View/download PDF
24. Self-Organizing Scale Free Topology for Peer-to-Peer Networks.
- Author
-
Eum, S., Arakawa, S., and Murata, M.
- Published
- 2009
- Full Text
- View/download PDF
25. Toward bio-inspired network robustness - Step 1. Modularity.
- Author
-
Eum, S., Arakawa, S., and Murata, M.
- Published
- 2007
- Full Text
- View/download PDF
26. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness.
- Author
-
Eum, S Y, primary, Hailé, S, additional, Lefort, J, additional, Huerre, M, additional, and Vargaftig, B B, additional
- Published
- 1995
- Full Text
- View/download PDF
27. Self-organizing name resolution system for ICN
- Author
-
Eum, S., Jibiki, M., Murata, M., Hitoshi Asaeda, and Nishinaga, N.
28. Metaplastic ossification in the cartilage of the bronchus of a patient with chronic multi-drug resistant tuberculosis: a case report
- Author
-
Barry III Clifton E, Via Laura E, Kim Jhingook, Cho Sang-Nae, Jeon Bo-Young, Kong Ji-Hye, Eum Seok-Yong, and Koh Won-Jung
- Subjects
Medicine - Abstract
Abstract Introduction Pulmonary ossification has been rarely observed in pulmonary fibrosis and in some chronic respiratory diseases such as chronic obstructive pulmonary disease. We report here a metaplastic ossification in the bronchial cartilage of a patient with multi-drug resistant tuberculosis. Case presentation We report the case of a 41-year-old Asian man from Korea with chronic multi-drug resistant tuberculosis with a rare focus of bone formation from the cartilage of a bronchus subtending an active cavity. The patient had a large multi-lobed, thick-walled cavitary tuberculosis lesion in his left upper lobe. Severe infiltration of his lymphocytes and epithelioid cells, along with some giant cells and neutrophils, was observed in the patient's bronchial wall. Desquamated bronchial epithelium and acid-fast bacilli were found inside his bronchus. A small focus of bony metaplasia was found in the cartilage of his bronchial wall. Histopathological examination confirmed calcification and showed hematopoietic cells forming in his marrow cavity. Conclusions Chronic inflammation in the lungs of our patient, caused by underlying tuberculosis, probably played a role in the development of osseous metaplasia from the associated cartilage of the bronchial wall.
- Published
- 2010
- Full Text
- View/download PDF
29. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
- Author
-
Lim KS, Jang I, Kim B, Kim J, Jeon J, Tae Y, Yi S, Eum S, Cho J, Shin S, and Yu K
- Abstract
BACKGROUND: Flecainide acetate is a class Ic antiarrythmic agent that is metabolized by the cytochrome P450 (CYP) 2D6 isozyme. A previous open-label, 2-period, single-sequence crossover study in healthy Korean male volunteers found differences in the pharmacokinetics of flecainide between subjects with the CYP2D6 wild-type allele and those with the CYP2D6*10 allele, as well as differences in the pharmacokinetic interaction between flecainide and the CYP2D6 inhibitor paroxetine between genotype groups. OBJECTIVE: This study evaluated QTc-interval changes after administration of a single oral dose of flecainide, with and without paroxetine, in relation to CYP2D6 genetic polymorphism. METHODS: This was a follow-on to the previous pharmacokinetic study and used data from the same group of healthy Korean male volunteers. Subjects were grouped by CYP2D6 genotype as follows: CYP2D6*1/*1 or CYP2D6*1/*2 (group 1, extensive metabolizers); CYP2D6*1/*10 (group 2, intermediate metabolizers); and CYP2D6*10/*010 or CYP2D6*10/*36 (group 3, poor metabolizers). Flecainide 200 mg was administered on day 1 (period 1); after a 7-day washout period, subjects received paroxetine 20 mg once daily from day 8 to day 14, and flecainide 200 mg on day 15 (period 2). On days 1 and 15, serial 12-lead ECGs were obtained before flecainide dosing and at 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, and 24 hours after dosing. Baseline ECGs were obtained at the same time points on days -1 and 14. Machine-read changes in the QT interval corrected using the Fridericia formula (QTcF) and manually read changes in the QT interval individually corrected using mixed-effects modeling (QTcI) from time-matched baseline were analyzed by genotype and by period (baseline and paroxetine-inhibited state). The QRS duration and JTc interval (QTcF - QRS) were also determined. RESULTS: Twenty-one healthy volunteers (mean [SD] age, 24.5 [3.0] years; mean height, 173.5 [4.6] cm; mean weight, 69.1 [4.5] kg), 7 in each group, were enrolled in and completed the study. In period 1, all genotype groups had significant increases from time-matched baseline in both the QTcF interval (group 1:17.4 milliseconds [90% CI, 9.9-24.9], P < 0.001; group 2: 11.1 milliseconds [90% CI, 7.9-14.3], P = 0.013; and group 3: 20.5 milliseconds [90% CI, 12.8-28.2], P < 0.001) and the QTcI interval (group 1:15.4 milliseconds [90% CI, 8.0-22.9], P = 0.001; group 2: 9.1 milliseconds [90% CI, 6.5-11.8], P = 0.030; and group 3:16.4 milliseconds [90% CI, 9.3-23.5], P = 0.001); the extent of increase did not differ significantly between groups. In groups 1 and 2, the least squares mean difference between period 1 and period 2 was statistically significant for the change in QTcF interval (6.5 milliseconds [90 CI, 3.2-9.8], P = 0.002; and 6.7 milliseconds [90% CI, 3.6-9.7], P = 0.001, respectively) and QTcI interval (6.9 milliseconds [90% CI, 4.1-9.8], P < 0.001; and 5.8 milliseconds [90% CI, 3.4-8.3], P < 0.001). In group 3, the least squares mean difference between period 1 and period 2 was statistically significant for the change in QTcI interval (3.9 milliseconds [90% CI, 1.3-6.5], P = 0.015) but not for the change in QT cF interval. The changes in QRS duration did not differ significantly by genotype or period. Consistent with the findings for the QTc interval, the least squares mean difference between period 1 and period 2 was statistically significant for the change in JTc interval in groups 1 and 2 (6.9 milliseconds [90% CI, 3.7-10.2], P = 0.001; and 5.4 milliseconds [90% CI, 2.7-8.2], P = 0.001, respectively) but not in group 3. CONCLUSION: The extent of drug interaction between flecainide and paroxetine, as reflected in the change in QTc interval (used as a pharmacodynamic biomarker), was influenced by the CYP2D6*10 allele in these healthy Korean male volunteers. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
30. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy.
- Author
-
Robinson KM, Eum S, Desta Z, Tyndale RF, Gaedigk A, Crist RC, Haidar CE, Myers AL, Samer CF, Somogyi AA, Zubiaur P, Iwuchukwu OF, Whirl-Carrillo M, Klein TE, Caudle KE, Donnelly RS, and Kharasch ED
- Subjects
- Humans, Opiate Substitution Treatment methods, Pharmacogenetics, Pharmacogenomic Variants, Analgesics, Opioid pharmacokinetics, Analgesics, Opioid adverse effects, Cytochrome P-450 CYP2B6 genetics, Cytochrome P-450 CYP2B6 metabolism, Genotype, Methadone pharmacokinetics, Methadone adverse effects, Opioid-Related Disorders drug therapy, Opioid-Related Disorders genetics
- Abstract
Methadone is a mu (μ) opioid receptor agonist used clinically in adults and children to manage opioid use disorder, neonatal abstinence syndrome, and acute and chronic pain. It is typically marketed as a racemic mixture of R- and S-enantiomers. R-methadone has 30-to 50-fold higher analgesic potency than S-methadone, and S-methadone has a greater adverse effect (prolongation) on the cardiac QTc interval. Methadone undergoes stereoselective metabolism. CYP2B6 is the primary enzyme responsible for catalyzing the metabolism of both enantiomers to the inactive metabolites, S- and R-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (S- and R-EDDP). Genetic variation in the CYP2B6 gene has been investigated in the context of implications for methadone pharmacokinetics, dose, and clinical outcomes. Most CYP2B6 variants result in diminished or loss of CYP2B6 enzyme activity, which can lead to higher plasma methadone concentrations (affecting S- more than R-methadone). However, the data do not consistently indicate that CYP2B6-based metabolic variability has a clinically significant effect on methadone dose, efficacy, or QTc prolongation. Expert analysis of the published literature does not support a change from standard methadone prescribing based on CYP2B6 genotype (updates at www.cpicpgx.org)., (© 2024 The Author(s). Clinical Pharmacology & Therapeutics © 2024 American Society for Clinical Pharmacology and Therapeutics.)
- Published
- 2024
- Full Text
- View/download PDF
31. A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals.
- Author
-
Kang DH, Yun SY, Eum S, Yoon KE, Ryu SR, Lee C, Heo HR, and Lee KM
- Abstract
Gram-negative bacterial endotoxins can cause pathophysiological effects such as high fever when introduced into the bloodstream. Therefore, endotoxin testing is necessary when producing injectable pharmaceuticals. The pharmaceutical industry has widely used Limulus amebocyte lysate (LAL) to certify product quality. However, ethical concerns have been raised and the increasing scarcity of Limulus polyphemus necessitates the development of novel testing techniques. Recombinant factor C (rFC) was developed using genetic engineering techniques. The aim of this study was to investigate the validity of rFC testing and compare it with the LAL method. The specificity, linearity, accuracy, precision, and robustness of the rFC assay were evaluated. After validation, the rFC assay was found to be suitable for endotoxin detection. We compared the accuracy of the rFC and LAL assays using reference standard endotoxin. The rFC assay was as accurate as the LAL assay. We also compared the two assays using biopharmaceuticals. Greater interference occurred in some samples when the rFC assay was used than when the LAL assay was used. However, the rFC assay overcame the interference when the samples were diluted. Overall, we suggest that rFC can be applied to test biopharmaceuticals.
- Published
- 2024
- Full Text
- View/download PDF
32. National trends in alcohol and substance use among adolescents from 2005 to 2021: a Korean serial cross-sectional study of one million adolescents.
- Author
-
Park S, Yon H, Ban CY, Shin H, Eum S, Lee SW, Shin YH, Shin JU, Koyanagi A, Jacob L, Smith L, Min C, Yeniova AÖ, Kim SY, Lee J, Hadalin V, Kwon R, Koo MJ, Fond G, Boyer L, Kim S, Hahn JW, Kim N, Lefkir E, Bondeville V, Rhee SY, Shin JI, Yon DK, and Woo HG
- Subjects
- Humans, Adolescent, Cross-Sectional Studies, Pandemics, Alcohol Drinking epidemiology, COVID-19 epidemiology, Substance-Related Disorders epidemiology
- Abstract
Background: Although previous studies have provided data on early pandemic periods of alcohol and substance use in adolescents, more adequate studies are needed to predict the trends of alcohol and substance use during recent periods, including the mid-pandemic period. This study investigated the changes in alcohol and substance use, except tobacco use, throughout the pre-, early-, and mid-pandemic periods in adolescents using a nationwide serial cross-sectional survey from South Korea., Methods: Data on 1,109,776 Korean adolescents aged 13-18 years from 2005 to 2021 were obtained in a survey operated by the Korea Disease Control and Prevention Agency. We evaluated adolescents' alcohol and substance consumption prevalence and compared the slope of alcohol and substance prevalence before and during the COVID-19 pandemic to see the trend changes. We define the pre-COVID-19 period as consisting of four groups of consecutive years (2005-2008, 2009-2012, 2013-2015, and 2016-2019). The COVID-19 pandemic period is composed of 2020 (early-pandemic era) and 2021 (mid-pandemic era)., Results: More than a million adolescents successfully met the inclusion criteria. The weighted prevalence of current alcohol use was 26.8% [95% confidence interval (CI) 26.4-27.1] from 2005 to 2008 and 10.5% (95% CI 10.1-11.0) in 2020 and 2021. The weighted prevalence of substance use was 1.1% (95% CI 1.1-1.2) from 2005 to 2008 and 0.7% (95% CI 0.6-0.7) between 2020 and 2021. From 2005 to 2021, the overall trend of use of both alcohol and drugs was found to decrease, but the decline has slowed since COVID-19 epidemic (current alcohol use: β
diff 0.167; 95% CI 0.150-0.184; substance use: βdiff 0.152; 95% CI 0.110-0.194). The changes in the slope of current alcohol and substance use showed a consistent slowdown with regard to sex, grade, residence area, and smoking status from 2005 to 2021., Conclusion: The overall prevalence of alcohol consumption and substance use among over one million Korean adolescents from the early and mid-stage (2020-2021) of the COVID-19 pandemic showed a slower decline than expected given the increase during the prepandemic period (2005-2019)., (© 2023. Children's Hospital, Zhejiang University School of Medicine.)- Published
- 2023
- Full Text
- View/download PDF
33. K-XMSS and K-SPHINCS + : Enhancing Security in Next-Generation Mobile Communication and Internet Systems with Hash Based Signatures Using Korean Cryptography Algorithms.
- Author
-
Sim M, Eum S, Song G, Yang Y, Kim W, and Seo H
- Abstract
As Mobile Communication and Internet Systems (MCIS) have rapidly developed, security issues related to MCIS have become increasingly important. Therefore, the development and research of security technologies for mobile communication and internet systems are actively being conducted. Hash-Based Signature (HBS) uses a hash function to construct a digital signature scheme, where its security is guaranteed by the collision resistance of the hash function used. To provide sufficient security in the post-quantum environment, the length of hash should be satisfied for the security requirement. Modern HBS can be classified into stateful and stateless schemes. Two representative stateful and stateless HBS are eXtended Merkle Signature Scheme(XMSS) and SPHINCS+, respectively. In this paper, we propose two HBS schemes: K-XMSS and K-SPHINCS+, which replace internal hash functions of XMSS and SPHINCS+ with Korean cryptography algorithms. K-XMSS is a stateful signature, while K-SPHINCS+ is its stateless counterpart. We showcase the reference implementation of K-XMSS and K-SPHINCS+ employing Lightweight Secure Hash (LSH) and two hash functions based on block ciphers (i.e., CHAM and LEA) as the internal hash function. In addition, K-XMSS and K-SPHINCS+ using Advanced Vector Extensions 2 (AVX2) have been provided, demonstrating that they can be optimized for better performance using advanced implementation techniques than previous approaches.
- Published
- 2023
- Full Text
- View/download PDF
34. The role of EZH1 and EZH2 in development and cancer.
- Author
-
Lee SH, Li Y, Kim H, Eum S, Park K, and Lee CH
- Subjects
- Humans, Chromatin, Enhancer of Zeste Homolog 2 Protein genetics, Enhancer of Zeste Homolog 2 Protein metabolism, Heterochromatin, Polycomb Repressive Complex 2 genetics, Polycomb Repressive Complex 2 metabolism, Histones metabolism, Neoplasms genetics
- Abstract
Polycomb Repressive Complex 2 (PRC2) exhibits key roles in mammalian development through its temporospatial repression of gene expression. EZH1 or EZH2 is the catalytic subunit of PRC2 that mediates the mono-, di- and tri-methylation of histone H3 lysine 27 (H3K27me1/2/3), H3K27me2/me3 being a hallmark of facultative heterochromatin. PRC2 is a chromatinmodifying enzyme that is recruited to a limited number of "nucleation sites", spreads H3K27 methylation and fosters chromatin compaction. EZH1 and EZH2 exhibit differences in their expression patterns, levels of histone methyltransferase activity (HMT) in the context of PRC2, and DNA/nucleosome binding activity. This suggests that their roles in heterochromatin formation are disparate. Dysregulation of PRC2 activity leads to aberrant gene expression and is implicated in cancer and developmental diseases. In this review, we discuss the distinct function of PRC2/EZH1 and PRC2/EZH2 in the early and late developmental stages. We then discuss the cancers associated with PRC2/EZH1 and PRC2/EZH2. [BMB Reports 2022; 55(12): 595-601].
- Published
- 2022
35. Burden of neurological diseases in Asia from 1990 to 2019: a systematic analysis using the Global Burden of Disease Study data.
- Author
-
Kang S, Eum S, Chang Y, Koyanagi A, Jacob L, Smith L, Shin JI, and Song TJ
- Subjects
- Humans, Global Burden of Disease, Quality-Adjusted Life Years, Incidence, Prevalence, Asia epidemiology, Global Health, Alzheimer Disease, Nervous System Diseases epidemiology, Migraine Disorders, Stroke
- Abstract
Objectives: The burden of neurological disorders is increasing worldwide, including Asia. The purpose of this study was to determine the burden of neurological disorders between 1990 and 2019 in Asia using the Global Burden of Disease (GBD) Sociodemographic Index., Design, Setting, Outcome and Participants: The GBD Study is updated every year and the most recent version provides the burden of diseases according to age, gender and region from 1990 to 2019. The burden of neurological disorders was evaluated as incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost and years lived with disability., Results: In 2019, DALYs of neurological diseases were 64.4 million in South-East Asia (95% uncertainty interval (UI) 45.2 to 94.2) and 85.0 million in Western Pacific regions (95% UI 63.0 to 118.5). Stroke, migraine, Alzheimer's disease and other dementias had the highest DALYs in the WHO South-East Asia and WHO Western Pacific regions in 2019. DALYs of stroke, Alzheimer's disease and other dementias, Parkinson's disease, brain and central nervous system cancer, multiple sclerosis, migraine and tension-type headache increased in both regions in 2019 compared with 1990. Infectious diseases such as tetanus, meningitis and encephalitis decreased in both regions. DALYs of idiopathic epilepsy and motor neuron disease increased in the WHO South-East Asia region and decreased in the WHO Western Pacific region., Conclusions: This study demonstrated the burden of neurological diseases in Asia. To reduce the burden of neurological diseases, strategies suitable for each country's real healthcare needs and challenges are needed; this study can serve as the cornerstone of these strategies., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
36. Considering medication exposure in genomic association studies of cognition in psychotic disorders.
- Author
-
Eum S, Hill SK, and Bishop JR
- Subjects
- Cognition, Genomics, Humans, Research, Cognitive Dysfunction drug therapy, Cognitive Dysfunction genetics, Psychotic Disorders drug therapy, Psychotic Disorders genetics
- Abstract
Cognitive dysfunction is a core feature of psychosis-spectrum illnesses, and the characterization of related genetic mechanisms may provide insights regarding the disease pathophysiology. Substantial efforts have been made to determine the genetic component of cognitive symptoms, without clear success. Illness-related moderators and environmental factors such as medications hinder the detection of genomic association with cognition. Polypharmacy is common in psychotic disorders, and the cumulative effects of medication regimens can confound gene-cognition associations. A review of the relative contributions of important pharmacological and genetic relationships identifies that the effects of medications on cognition in psychotic disorders may be at least, if not more, impactful than individual genes, thus underscoring the importance of accounting for medication exposure in gene-cognition association studies.
- Published
- 2022
- Full Text
- View/download PDF
37. Plasma osteoprotegerin level is associated with hemorrhagic transformation in stroke patients who underwent endovascular thrombectomy.
- Author
-
Kim HJ, Park MS, Joo A, Kang S, Eum S, Chang Y, and Song TJ
- Subjects
- Humans, Odds Ratio, Osteoprotegerin, Thrombectomy methods, Treatment Outcome, Brain Ischemia pathology, Endovascular Procedures, Ischemic Stroke surgery, Stroke
- Abstract
Objective: Osteoprotegerin (OPG) is a component of the tumor necrosis factor receptor superfamily. Several studies have shown a relationship between OPG and cardiovascular disease. We investigated the association between plasma OPG levels and hemorrhagic transformation in stroke patients who received endovascular thrombectomy (EVT)., Methods: We prospectively enrolled 360 patients diagnosed with acute ischemic stroke and performed EVT from April 2014 to December 2020. Blood sampling for plasma OPG was performed after fasting for 12 h after EVT. Hemorrhagic transformation was defined using the definition and classification of the European Cooperative Acute Stroke Study-3 trial., Results: Of all the included patients, 130 (36.1%) experienced hemorrhagic transformation. The mean ± standard deviation of the plasma OPG concentrations was 200.2 ± 74.4 pg/mL. In multivariable analysis, after adjusting for age, sex, body mass index (BMI), and variables with p < 0.1 in univariable analysis (diabetes mellitus, atrial fibrillation, coronary artery disease, alcohol intake, current smoking, NIHSS, ASPECT score, mass effect, hemoglobin, vitamin D 25(OH)D), increased plasma OPG concentration was independently related to any hemorrhagic transformation (highest tertile vs. lowest tertile of OPG; odds ratio [OR] 2.31, 95% confidence interval [CI] (1.29-4.14), p = 0.005) and severity of hemorrhagic transformation (OR 2.92, 95% CI (1.66-5.12), p = 0.001)., Conclusions: Our results demonstrate that increased plasma OPG level is related to the occurrence and severity of hemorrhagic transformation in patients with cerebral infarction who receive EVT., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
38. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.
- Author
-
Zhang L, Hill SK, Guo B, Wu B, Alliey-Rodriguez N, Eum S, Lizano P, Ivleva EI, Reilly JL, Keefe RSE, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, and Bishop JR
- Subjects
- Adult, Female, Humans, Male, Neuropsychological Tests statistics & numerical data, White People statistics & numerical data, Cardiovascular Agents adverse effects, Cognitive Dysfunction etiology, Coronary Artery Disease genetics, Psychotic Disorders complications
- Abstract
Background: Cognitive impairment is a core deficit across psychotic disorders, the causes and therapeutics of which remain unclear. Epidemiological observations have suggested associations between cognitive dysfunction in psychotic disorders and cardiovascular risk factors, but an underlying etiology has not been established., Methods: Neuropsychological performance using the Brief Assessment of Cognition in Schizophrenia (BACS) was assessed in 616 individuals of European ancestry (403 psychosis, 213 controls). Polygenic risk scores for coronary artery disease (PRS
CAD ) were quantified for each participant across 13 p-value thresholds (PT 0.5-5e-8 ). Cardiovascular and psychotropic medications were categorized for association analyses. Each PRSCAD was examined in relation to the BACS and the optimized PT was confirmed with five-fold cross-validation and independent validation. Functional enrichment analyses were used to identify biological mechanisms linked to PRSCAD -cognition associations. Multiple regression analyses examined PRSCAD under the optimal PT and medication burden in relation to the BACS composite and subtest scores., Results: Higher PRSCAD was associated with lower BACS composite scores (p = 0.001) in the psychosis group, primarily driven by the Verbal Memory subtest (p < 0.001). Genes linked to multiple nervous system related processes and pathways were significantly enriched in PRSCAD . After controlling for PRSCAD , a greater number of cardiovascular medications was also correlated with worse BACS performance in patients with psychotic disorders (p = 0.029)., Conclusions: Higher PRSCAD and taking more cardiovascular medications were both significantly associated with cognitive impairment in psychosis. These findings indicate that cardiovascular factors may increase the risk for cognitive dysfunction and related functional outcomes among individuals with psychotic disorders., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
39. Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis.
- Author
-
Eum S, Sayre F, Lee AM, Stingl JC, and Bishop JR
- Subjects
- Bupropion therapeutic use, Genotype, Humans, Polymorphism, Genetic genetics, Bupropion analogs & derivatives, Cytochrome P-450 CYP2B6 genetics
- Abstract
Introduction: Bupropion is metabolized to its active metabolite, hydroxybupropion (HB), by the genetically polymorphic cytochrome P450 2B6 (CYP2B6) enzyme. Despite its significant role in bupropion metabolism, the magnitude of the impact of CYP2B6 genotype on the exposure of bupropion has not been quantified., Objectives: A systematic review and meta-analysis was conducted to quantify the association of bupropion and HB exposure with CYP2B6 variant alleles and genotype-defined metabolizer phenotypes., Methods: MEDLINE, EMBASE, Web of Science, Scifinder, PsycINFO, and CENTRAL were screened to identify studies that met the following inclusion criteria (search updated on February 2021): (1) area under the plasma drug concentration-time curve (AUC) of bupropion and/or HB in relation to CYP2B6 genotypes was studied, and (2) study participants were genotyped for common CYP2B6 variant alleles including at least CYP2B6*6. The Newcastle Ottawa Scale was used to assess risk of bias in each included study. The ratio of means (RoM) between CYP2B6 genotype or genotype-defined phenotype groups for bupropion exposure was calculated for each study and combined in a meta-analysis., Results: Eleven studies met the inclusion criteria for this systematic review, and 10 (including N = 413 participants) were included in the meta-analysis. All 10 studies involved healthy adult volunteers, where other medications were not allowed. The AUCs of HB and the active moiety (bupropion + HB) were significantly reduced in CYP2B6*6 carriers compared with the non-carriers (HB: RoM 0.77, 95% CI 0.71-0.83; active moiety: RoM 0.81, 95% CI 0.75-0.88). Both CYP2B6 poor and intermediate metabolizers had significantly decreased exposures to HB and the active moiety than normal metabolizers., Conclusion: The CYP2B6*6 allele and genotype-determined CYP2B6 poor and intermediate metabolizer phenotypes are associated with significantly lower exposures to HB and the total active moiety. The findings of this study suggest opportunities to further study precision dosing strategies for bupropion therapy based on CYP2B6 genotype., (© 2021 Pharmacotherapy Publications, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
40. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
- Author
-
Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, Keshavan MS, Gershon ES, Sweeney JA, and Bishop JR
- Subjects
- Cholinergic Antagonists adverse effects, Genome-Wide Association Study, Humans, Cognitive Dysfunction chemically induced, Cognitive Dysfunction genetics, Psychotic Disorders complications, Psychotic Disorders drug therapy, Psychotic Disorders genetics, Schizophrenia complications, Schizophrenia drug therapy, Schizophrenia genetics
- Abstract
Identifying genetic contributors to cognitive impairments in psychosis-spectrum disorders can advance understanding of disease pathophysiology. Although CNS medications are known to affect cognitive performance, they are often not accounted for in genetic association studies. In this study, we performed a genome-wide association study (GWAS) of global cognitive performance, measured as composite z-scores from the Brief Assessment of Cognition in Schizophrenia (BACS), in persons with psychotic disorders and controls (N = 817; 682 cases and 135 controls) from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Analyses accounting for anticholinergic exposures from both psychiatric and non-psychiatric medications revealed five significantly associated variants located at the chromosome 3p21.1 locus, with the top SNP rs1076425 in the inter-alpha-trypsin inhibitor heavy chain 1 (ITIH1) gene (P = 3.25×E-9). The inclusion of anticholinergic burden improved association models (P < 0.001) and the number of significant SNPs identified. The effect sizes and direction of effect of the top variants remained consistent when investigating findings within individuals receiving specific antipsychotic drugs and after accounting for antipsychotic dose. These associations were replicated in a separate study sample of untreated first-episode psychosis. The chromosome 3p21.1 locus was previously reported to have association with the risk for psychotic disorders and cognitive performance in healthy individuals. Our findings suggest that this region may be a psychosis risk locus that is associated with cognitive mechanisms. Our data highlight the general point that the inclusion of medication exposure information may improve the detection of gene-cognition associations in psychiatric genetic research., (© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.)
- Published
- 2021
- Full Text
- View/download PDF
41. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis.
- Author
-
Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, Keshavan MS, Sweeney JA, and Bishop JR
- Subjects
- Brain diagnostic imaging, Cognition, Humans, Magnetic Resonance Imaging, Bipolar Disorder, Psychotic Disorders, Schizophrenia
- Abstract
Elevations in peripheral inflammatory markers have been reported in patients with psychosis. Whether this represents an inflammatory process defined by individual or subgroups of markers is unclear. Further, relationships between peripheral inflammatory marker elevations and brain structure, cognition, and clinical features of psychosis remain unclear. We hypothesized that a pattern of plasma inflammatory markers, and an inflammatory subtype established from this pattern, would be elevated across the psychosis spectrum and associated with cognition and brain structural alterations. Clinically stable psychosis probands (Schizophrenia spectrum, n = 79; Psychotic Bipolar disorder, n = 61) and matched healthy controls (HC, n = 60) were assessed for 15 peripheral inflammatory markers, cortical thickness, subcortical volume, cognition, and symptoms. A combination of unsupervised exploratory factor analysis and hierarchical clustering was used to identify inflammation subtypes. Levels of IL6, TNFα, VEGF, and CRP were significantly higher in psychosis probands compared to HCs, and there were marker-specific differences when comparing diagnostic groups. Individual and/or inflammatory marker patterns were associated with neuroimaging, cognition, and symptom measures. A higher inflammation subgroup was defined by elevations in a group of 7 markers in 36% of Probands and 20% of HCs. Probands in the elevated inflammatory marker group performed significantly worse on cognitive measures of visuo-spatial working memory and response inhibition, displayed elevated hippocampal, amygdala, putamen and thalamus volumes, and evidence of gray matter thickening compared to the proband group with low inflammatory marker levels. These findings specify the nature of peripheral inflammatory marker alterations in psychotic disorders and establish clinical, neurocognitive and neuroanatomic associations with increased inflammatory activation in psychosis. The identification of a specific subgroup of patients with inflammatory alteration provides a potential means for targeting treatment with anti-inflammatory medications., (© 2020. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2021
- Full Text
- View/download PDF
42. Corrigendum: Methylation of FKBP5 and SLC6A4 in Relation to Treatment Response to Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder.
- Author
-
Bishop JR, Lee AM, Mills LJ, Thuras PD, Eum S, Clancy D, Erbes CR, Polusny MA, Lamberty GJ, and Lim KO
- Abstract
[This corrects the article DOI: 10.3389/fpsyt.2018.00418.]., (Copyright © 2021 Bishop, Lee, Mills, Thuras, Eum, Clancy, Erbes, Polusny, Lamberty and Lim.)
- Published
- 2021
- Full Text
- View/download PDF
43. Identification of Nontuberculous Mycobacteria in Patients with Pulmonary Diseases in Gyeongnam, Korea, Using Multiplex PCR and Multigene Sequence-Based Analysis.
- Author
-
Kim MJ, Kim KM, Shin JI, Ha JH, Lee DH, Choi JG, Park JS, Byun JH, Yoo JW, Eum S, Jung M, Baik SC, Lee WK, Kang HL, and Shin MK
- Abstract
Background: Nontuberculous mycobacteria (NTM) are widely present in environments, such as soil and water, and have recently been recognized as important pathogenic bacteria. The incidence of NTM-related infections is steadily increasing. As the diagnosis and treatment of NTM infection should be distinguished from tuberculosis, and the treatment should be specific to the species of NTM acquired, accurate species identification is required., Methods: In this study, two-step multiplex PCR (mPCR) and multigene sequence-based analysis were used to accurately identify NTM species in 320 clinical isolates from Gyeongsang National University Hospital (GNUH). In particular, major mycobacterial strains with a high isolation frequency as well as coinfections with multiple species were diagnosed through two-step mPCR. Multigene sequencing was performed to accurately identify other NTM species not detected by mPCR. Variable regions of the genes 16S rRNA, rpoB , hsp65 , and 16S-23S rRNA internal transcribed spacer were included in the analysis., Results: Two-step mPCR identified 234 (73.1%) cases of M . intracellulare , 26 (8.1%) cases of M . avium subsp. avium , and 13 (4.1%) cases of M . avium subsp. hominissuis infection. Additionally, 9 (2.8%) M . fortuitum , 9 (2.8%) M . massiliense , 2 (0.6%) M . abscessus , and 4 (1.2%) M . kansasii isolates were identified. Coinfection was identified in 7 (2.2%) samples. The sixteen samples not classified by two-step mPCR included 6 (1.9%) cases of M . chimaera , 4 (1.3%) M . gordonae , 1 (0.3%) M . colombiense , 1 (0.3%) M . mageritense , and 1 (0.3%) M . persicum identified by sequence analysis., Conclusions: The results of this study suggest a strategy for rapid detection and accurate identification of species using two-step mPCR and multigene sequence-based analysis. To the best of our knowledge, this study is the first to report the identification of NTM species isolated from patients in Gyeongnam/Korea., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2021 Min-Jeong Kim et al.)
- Published
- 2021
- Full Text
- View/download PDF
44. Genome Wide Epistasis Study of On-Statin Cardiovascular Events with Iterative Feature Reduction and Selection.
- Author
-
Adams SM, Feroze H, Nguyen T, Eum S, Cornelio C, and Harralson AF
- Abstract
Predicting risk for major adverse cardiovascular events (MACE) is an evidence-based practice that incorporates lifestyle, history, and other risk factors. Statins reduce risk for MACE by decreasing lipids, but it is difficult to stratify risk following initiation of a statin. Genetic risk determinants for on-statin MACE are low-effect size and impossible to generalize. Our objective was to determine high-level epistatic risk factors for on-statin MACE with GWAS-scale data. Controlled-access data for 5890 subjects taking a statin collected from Vanderbilt University Medical Center's BioVU were obtained from dbGaP. We used Random Forest Iterative Feature Reduction and Selection (RF-IFRS) to select highly informative genetic and environmental features from a GWAS-scale dataset of patients taking statin medications. Variant-pairs were distilled into overlapping networks and assembled into individual decision trees to provide an interpretable set of variants and associated risk. 1718 cases who suffered MACE and 4172 controls were obtained from dbGaP. Pathway analysis showed that variants in genes related to vasculogenesis (FDR = 0.024), angiogenesis (FDR = 0.019), and carotid artery disease (FDR = 0.034) were related to risk for on-statin MACE. We identified six gene-variant networks that predicted odds of on-statin MACE. The most elevated risk was found in a small subset of patients carrying variants in COL4A2 , TMEM178B , SZT2 , and TBXAS1 (OR = 4.53, p < 0.001). The RF-IFRS method is a viable method for interpreting complex "black-box" findings from machine-learning. In this study, it identified epistatic networks that could be applied to risk estimation for on-statin MACE. Further study will seek to replicate these findings in other populations.
- Published
- 2020
- Full Text
- View/download PDF
45. CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta-analysis.
- Author
-
Zhang L, Brown SJ, Shan Y, Lee AM, Allen JD, Eum S, de Leon J, and Bishop JR
- Subjects
- Antipsychotic Agents blood, Cytochrome P-450 CYP2D6 metabolism, Humans, Polymorphism, Genetic, Risperidone blood, Antipsychotic Agents pharmacokinetics, Cytochrome P-450 CYP2D6 genetics, Risperidone pharmacokinetics
- Abstract
Background: Risperidone is a second-generation antipsychotic drug metabolized to an active metabolite, 9-hydroxyrisperidone, primarily by cytochrome P450 (CYP) 2D6 and to a lesser extent by CYP3A4. The extent to which drug metabolism genetics impacts risperidone and 9-hydroxyrisperidone exposure has not been clarified., Objective: A systematic review and meta-analysis evaluated the impact of genetically defined CYP2D6 function on risperidone pharmacokinetics applying a standardized genotype-phenotype translation system., Methods: A comprehensive electronic database search identified studies reporting relationships between genetically determined CYP2D6 metabolism and risperidone pharmacokinetic properties. The exposure of risperidone or active moiety (risperidone + 9-hydroxyrisperidone) was measured by dose-adjusted steady-state serum or plasma concentration or area under the concentration-time curve as primary outcomes. Subjects were assigned to CYP2D6 poor metabolizer, intermediate metabolizer, normal metabolizer, or ultrarapid metabolizer groups using a standardized genotype-phenotype translation method. Effect sizes between groups were pooled and stratified by single or multiple dosing regimens., Results: A total of 15 studies involving 2125 adult subjects were included in the meta-analysis. Following multiple-dose oral administration, compared with CYP2D6 normal metabolizers, the risperidone dose-adjusted steady-state serum/plasma concentration was 2.35-fold higher in intermediate metabolizers (95% confidence interval [CI] 1.77-3.13, p<0.0001) and 6.20-fold higher in poor metabolizers (95% CI 5.05-7.62, p<0.0001); the active moiety dose-adjusted steady-state concentration was 1.18-fold higher in intermediate metabolizers (95% CI 1.11-1.25, p<0.0001) and 1.44-fold higher in poor metabolizers (95% CI 1.23-1.69, p<0.0001). Higher area under the concentration-time curve of risperidone and active moiety was also found in single-dose studies., Conclusion: Genetically defined impaired CYP2D6 activity is associated with increased exposure of both risperidone and risperidone + 9-hydroxyrisperidone in adults receiving oral formulations. Additional studies are needed to quantify the clinical impact of these relationships., (© 2020 Pharmacotherapy Publications, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
46. Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry.
- Author
-
Brown L, Eum S, Haga SB, Strawn JR, and Zierhut H
- Subjects
- Genetic Counseling, Genetic Testing, Health Care Sector, Humans, Implementation Science, Pharmacists, Pharmacogenetics, Psychiatry methods
- Abstract
Introduction: The use of pharmacogenomic (PGx) testing to guide decisions and improve patient outcomes has increased in recent years. PGx testing represents a decision support tool that may inform dosing, increase the likelihood of treatment response, and identify patients at risk for medication side effects., Methods: This is a narrative review of utilization of PGx testing in psychiatry from stakeholders including, pharmacists, genetic counselors, implementation scientists, industry, and clinicians., Results: While many limitations exist to streamline use of PGx testing in psychiatry, various stakeholders are crucial to clinical implementation., Discussion: PGx testing can assist in medication selection and improve patient outcomes; however, more data are needed to understand when and how to incorporate PGx testing into psychiatric practice., Competing Interests: Dr. Lisa Brown is an employee and stockholder of Myriad Genetics, producer of a pharmacogenetic test. Dr. Seenae Eum has no related conflicts to declare. Dr. Susanne Haga has received research support from the National Institutes of Health (NIGMS). Dr. Jeffrey Strawn has received research support from the National Institutes of Health (NIMH, NIEHS, NICHD) as well as Allergan, Otsuka, Neuronetics and The Yung Family Foundation. He has received material support from and provided consultation to Myriad Genetics. Dr. Strawn also receives royalties from the publication of two texts (Springer) and serves as an author for UpToDate and an Associate Editor for Current Psychiatry. Dr. Heather Zeirhut receives research support from the National Society of Genetic Counselors. She is a Senior Advisor and Chair of the Advisory Board for GeneMatters, LLC, a tele- genetic counseling company., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2020
- Full Text
- View/download PDF
47. Annona squamosa L. leaves inhibit alpha-melanocyte-stimulating hormone (α-MSH) stimulated melanogenesis via p38 signaling pathway in B16F10 melanoma cells.
- Author
-
Ko GA, Kang HR, Moon JY, Ediriweera MK, Eum S, Bach TT, and Cho SK
- Subjects
- Animals, Cell Line, Tumor, Melanins, Mice, Microphthalmia-Associated Transcription Factor metabolism, Monophenol Monooxygenase metabolism, Plant Extracts pharmacology, Signal Transduction, alpha-MSH pharmacology, Annona metabolism, Melanoma, Experimental drug therapy
- Abstract
Background: Annona squamosa L. is a branched shrub, which is believed to be originated from the America and West Indies. Fruits of this plant are commonly known as custard apple, sugar apple, or sweetsops. A number of studies have proven a range of biological activities associated with various parts of A. squamosa., Aims: The main aim of the present investigation was to evaluate potential inhibitory effects of A. squamosa leaf extract (ALE) on melanogenesis and its underlying mechanisms in B16F10 murine melanoma cells., Methods: Inhibitory effects of A. squamosa leaf extract (ALE) on melanogenesis were primarily assessed by determining melanin contents. Effects of ALE on tyrosinase activity and the expression of proteins associated with melanogenesis were then determined. GC-MS analysis was carried out to identify the phytochemical profile of A. squamosa leaf extract., Results: Antimelanogenic effects of ALE were found to exert through the inhibition of melanocyte inducing transcription factor (MITF) and activation of p38. GC-MS analysis identified ent-kaur-16-en-19-ol, 18-oxokauran-17-yl acetate, and β-sitosterol as major phytochemicals., Conclusion: To our knowledge, this is the first study on the antimelanogenic effects of A. squamosa leaves, rationalizing the use A. squamosa leaf extract as a natural depigmentation agent for the treatment of skin diseases and the development of cosmetic products with enhanced skin-lightening capabilities., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
48. Anti‑inflammatory role of Prunus persica L. Batsch methanol extract on lipopolysaccharide‑stimulated glial cells.
- Author
-
Seo KH, Choi SY, Jin Y, Son H, Kang YS, Jung SH, Kim YI, Eum S, Bach TT, Yoo HM, Whang WK, Jung SY, Kang W, Ko HM, and Lee SH
- Subjects
- Animals, Anti-Inflammatory Agents therapeutic use, Antioxidants pharmacology, Cytokines metabolism, Female, Inflammation Mediators, Interleukin-1beta metabolism, Interleukin-6 metabolism, Male, Methanol, Mitogen-Activated Protein Kinase Kinases metabolism, Mitogen-Activated Protein Kinases drug effects, Mitogen-Activated Protein Kinases metabolism, Nitric Oxide metabolism, Nitric Oxide Synthase Type II metabolism, Nitrites metabolism, Plant Extracts chemistry, Rats, Rats, Sprague-Dawley, Tumor Necrosis Factor-alpha metabolism, Anti-Inflammatory Agents pharmacology, Lipopolysaccharides adverse effects, Neuroglia drug effects, Plant Extracts pharmacology, Prunus persica chemistry
- Abstract
Glial cells are the resident immune cells of the central nervous system. Reactive glial cells release inflammatory mediators that induce neurotoxicity or aggravate neurodegeneration. Regulation of glial activation is crucial for the initiation and progression of neuropathological conditions. Constituents of the peach tree (Prunus persica L. Batsch), which has a global distribution, have been found to exert therapeutic effects in pathological conditions, such as rashes, eczema and allergies. However, the therapeutic potential of its aerial parts (leaves, fruits and twigs) remains to be elucidated. The present study aimed to evaluate the anti‑inflammatory role of P. persica methanol extract (PPB) on lipopolysaccharide (LPS)‑stimulated glial cells. High‑performance liquid chromatography coupled with tandem mass spectrometry analysis showed that PPB contained chlorogenic acid and catechin, which have antioxidant properties. Western blot and reverse transcription polymerase chain reaction results indicated that PPB reduced the transcription of various proinflammatory enzymes (nitric oxide synthase and cyclooxygenase‑2) and cytokines [tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑6] in LPS‑stimulated BV2 cells. In addition, PPB inhibited the activation of NF‑κB and various mitogen‑activated protein kinases required for proinflammatory mediator transcription. Finally, nitrite measurement and immunocytochemistry results indicated that PPB also suppressed nitrite production and NF‑κB translocation in LPS‑stimulated primary astrocytes. Thus, PPB may be used as a potential therapeutic agent for neurodegenerative diseases and neurotoxicity via the suppression of glial cell activation.
- Published
- 2020
- Full Text
- View/download PDF
49. Brain gray matter network organization in psychotic disorders.
- Author
-
Zhang W, Lei D, Keedy SK, Ivleva EI, Eum S, Yao L, Tamminga CA, Clementz BA, Keshavan MS, Pearlson GD, Gershon ES, Bishop JR, Gong Q, Lui S, and Sweeney JA
- Subjects
- Adult, Female, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Psychotic Disorders genetics, Psychotic Disorders psychology, Young Adult, Brain diagnostic imaging, Gray Matter diagnostic imaging, Nerve Net diagnostic imaging, Psychotic Disorders diagnostic imaging
- Abstract
Abnormal neuroanatomic brain networks have been reported in schizophrenia, but their characterization across patients with psychotic disorders, and their potential alterations in nonpsychotic relatives, remain to be clarified. Participants recruited by the Bipolar and Schizophrenia Network for Intermediate Phenotypes consortium included 326 probands with psychotic disorders (107 with schizophrenia (SZ), 87 with schizoaffective disorder (SAD), 132 with psychotic bipolar disorder (BD)), 315 of their nonpsychotic first-degree relatives and 202 healthy controls. Single-subject gray matter graphs were extracted from structural MRI scans, and whole-brain neuroanatomic organization was compared across the participant groups. Compared with healthy controls, psychotic probands showed decreased nodal efficiency mainly in bilateral superior temporal regions. These regions had altered morphological relationships primarily with frontal lobe regions, and their network-level alterations were associated with positive symptoms of psychosis. Nonpsychotic relatives showed lower nodal centrality metrics in the prefrontal cortex and subcortical regions, and higher nodal centrality metrics in the left cingulate cortex and left thalamus. Diagnosis-specific analysis indicated that individuals with SZ had lower nodal efficiency in bilateral superior temporal regions than controls, probands with SAD only exhibited lower nodal efficiency in the left superior and middle temporal gyrus, and individuals with psychotic BD did not show significant differences from healthy controls. Our findings provide novel evidence of clinically relevant disruptions in the anatomic association of the superior temporal lobe with other regions of whole-brain networks in patients with psychotic disorders, but not in their unaffected relatives, suggesting that it is a disease-related trait. Network disorganization primarily involving frontal lobe and subcortical regions in nonpsychotic relatives may be related to familial illness risk.
- Published
- 2020
- Full Text
- View/download PDF
50. ME R-CNN: Multi-Expert R-CNN for Object Detection.
- Author
-
Lee H, Eum S, and Kwon H
- Abstract
We introduce Multi-Expert Region-based Convolutional Neural Network (ME R-CNN) which is equipped with multiple experts (ME) where each expert is learned to process a certain type of regions of interest (RoIs). This architecture better captures the appearance variations of the RoIs caused by different shapes, poses, and viewing angles. In order to direct each RoI to the appropriate expert, we devise a novel "learnable" network, which we call, expert assignment network (EAN). EAN automatically learns the optimal RoI-expert relationship even without any supervision of expert assignment. As the major components of ME R-CNN, ME and EAN, are mutually affecting each other while tied to a shared network, neither an alternating nor a naive end-to-end optimization is likely to fail. To address this problem, we introduce a practical training strategy which is tailored to optimize ME, EAN, and the shared network in an end-to-end fashion. We show that both of the architectures provide considerable performance increase over the baselines on PASCAL VOC 07, 12, and MS COCO datasets.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.